Intranasal Vasopressin Treatment in Children With Autism

Clinical trial NCT03204786 · COMPLETED

Trial details

NCT number: NCT03204786
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Autism Autism Spectrum Disorder ASD

Start date: 2018-02-20
Primary completion: 2024-03-18
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.